Antimicrobial peptides (AMPs) are key effectors of the innate immune system and promising ther-28 apeutic agents. Yet, knowledge on how to design AMPs with minimal cross-resistance to human 29 host-defense peptides remains limited. Here, with a chemical-genetic approach, we systemati-30 cally assessed the resistance determinants of Escherichia coli against 15 different AMPs. Alt-31 hough generalizations about AMP resistance are common in the literature, we found that AMPs 32 with different physicochemical properties and cellular targets vary considerably in their resistance 33 determinants. As a consequence, collateral sensitivity effects were common: numerous genes 34 decreased susceptibility to one AMP while simultaneously sensitized to others. Finally, the chem-
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Taken together, AMPs with similar chemical-genetic profiles share physicochemical fea-157 tures and previously described broad mechanisms of action, indicating that chemical-genetics 158 can capture certain differences in the bactericidal effects across AMPs.
160
Large and functionally diverse set of genes influences AMP resistance 161 We identified between 88 -778 and 348 -1263 genes enhancing resistance and sensitivity per 162 AMP, respectively (Figure 3a ). This finding substantially broadens the scope of genes that en-163 hance resistance (latent resistome), as previously reported resistance genes in E. coli constitute 164 only 0.46% (11 of 2371) of the resistance-conferring genes identified here (Supplementary Table   165 6). Importantly, whereas genes annotated with cell envelope function were overrepresented 166 among AMP susceptibility modulating genes ( Supplementary Table 7 ), the majority of our hits did 167 not have obvious functional connection with known AMP uptake mechanism or mode of action 168 ( Supplementary Figure 4 ).
169
Next, to assess the diversity of resistance determinants across AMPs, we calculated the 170 extent to which the resistance-and sensitivity-conferring genes are shared between pairs of 171 AMPs. To avoid underestimating the overlap between gene sets across AMPs, we employed an 172 index of overlap that takes into account measurement noise (see Methods). Typically, ~63 % of 173 the sensitive and ~31 % of the resistance genes overlapped between pairs of AMPs (Supplemen-174 tary Figure 5 ). The latter figure indicates substantial variation in the latent resistome across AMPs.
175
Remarkably, the sets of resistance-conferring genes varied greatly even between AMPs in the 176 same chemical-genetic cluster, in particular between AMPs in cluster C3 (Figure 3b ). This pattern 177 could reflect subtle differences in the modes of action across the intracellular-targeting AMPs 178 within cluster C3 as these peptides differ in their specific targets (Table 1) Chemical-genetic profiling based on gene depletion captures a different aspect of resistance de-187 terminants than gene overexpression 32 . While resistance upon increased gene dosage informs 188 on the latent resistome, hypersensitivity upon gene depletion reveals genes that contribute to 7 resistance at their native expression levels, collectively called as the intrinsic resistome 26 . To in-190 vestigate the intrinsic AMP resistome, we initiated a chemical-genetic screen with a set of 279 191 partially-depleted essential genes (hypomorphic alleles) of E. coli. We selected four AMPs with 192 well-characterized modes of action, including two membrane-targeting (Pexiganan (PEX) and 193 LL37 from C2) and two intracellular-targeting AMPs (BAC5 and PR39 from C4). Then, using a 194 well-established high-density agar plate assay 21,22,33 , we determined their chemical-genetic inter-195 action profiles across the hypomorphic alleles (Methods, Supplementary Table 8 ).
196
In total, we found that 75% of the 279 partially-depleted essential genes influenced sus-197 ceptibility to at least one of the AMPs studied and 60% of these interactions caused hypersensi-198 tivity, indicating that essential genes often contribute to the intrinsic AMP resistome (Supplemen-199 tary Table 8 ). We found substantial overlaps in the intrinsic resistomes between AMPs with similar 200 modes of action. As high as 87% of the 279 hypomorphic alleles overlapped between PEX and 201 LL37, and a similar figure emerged from the comparison of the gene set between BAC5 and PR39 202 ( Figure 3d ). In contrast, on average, only 59% of the 279 hypomorphic alleles were identical when 203 functionally dissimilar AMPs were compared ( Figure 3d ).
204
Genes that simultaneously confer drug resistance when overexpressed and sensitivity 205 when depleted are of special interest as such genes are likely to directly protect bacteria against 206 drug stress or encode drug targets 34 . Comparison of our overexpression and hypomorphic 207 screens revealed dozens of essential genes that showed both properties ( Figure 3e ). Remarka-208 bly, folA (dihydrofolate reductase), a known intracellular target of PR39 35 , was among the set of 209 6 genes that simultaneously conferred resistance when overexpressed and sensitivity when de-210 pleted in the presence of PR39. Similarly, pssA (a phosphatidylserine synthase) appeared in the 211 presence of LL37, a membrane-targeting AMP. Reassuringly, deletion of pssA has been shown 212 to alter membrane properties and increase bacterial sensitivity to membrane-targeting peptides 36 .
213
Together, these results indicate that both the intrinsic and the latent AMP resistomes are The limited overlap in resistance determinants across AMPs prompted us to hypothesize that 219 some of the gene overexpressions might even have antagonistic effects against distinct AMPs.
220
Specifically, we sought to identify resistance genes that induce collateral sensitivity, i.e. increase 221 resistance to one AMP while simultaneously sensitize to another one 37,38 . We found numerous 222 8 such cases ( Supplementary Table 6 ). For example, out of the 4,400 genes, we retrieved 643 that 223 conferred resistance to 2 or more AMPs while increasing sensitivity to at least 2 other AMPs upon 224 overexpression.
225
For each pair of AMP, we then calculated the overrepresentation of collateral sensitivity- 
233
Perturbed phospholipid trafficking as a mechanism of collateral sensitivity
234
We next focused on genes that showed reduced susceptibility to at least 4 membrane-targeting 235 AMPs upon overexpression while at the same time showed elevated susceptibilities toward at 236 least 4 intracellular-targeting AMPs. These genes were enriched in functions related to phospho- 
243
What could be the mechanism behind the antagonistic action of this pathway on mem- 
270
To test this notion, we performed an adaptive laboratory evolution experiment against hu-271 man-B-defensin-3 (HBD-3). We have chosen this AMP due to its relevance as a human host-272 defense peptide, and because its chemical-genetic profile is similar to AMPs belonging to cluster 273 C2, but markedly different from the rest of AMPs (Figure 1c Supplementary Table 9 ).
280
We then measured how the susceptibility of the four evolved lines changed to a set of 10 281 AMPs representing the four major chemical-genetic clusters (C1 to C4). We found that high levels 282 of cross-resistance occurred only to AMPs that were clustered together with HBD-3 in the chem-283 ical-genetic map (C2), while cross-resistance to AMPs belonging to the other three clusters (C1, 284 C3, C4) were rare ( Figure 6a ). These results demonstrate that clustering of the chemical-genetic 285 profiles predicted the observed cross-resistance patterns of the HBD-3-adapted lines.
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Next, we interrogated if the chemical-genetic profiles provide an insight into the molecular 287 mechanisms underlying the cross-resistance patterns of the HBD-3-evolved lines. To this end,
288
we first analyzed the function of the mutated genes. Phospholipid and LPS-related genes were 289 overrepresented among the mutated genes ( Supplementary Figure 11a ). Specifically, three HBD-290 3-evolved lines carried mutations in genes involved in retrograde phospholipid transport (Mla 291 pathway, see Supplementary Table 9 ). As overexpression of genes in this pathway induced re-292 sistant chemical-genetic interactions to membrane-targeting peptides only (Supplementary Figure   293 7 and 11b), we hypothesized that the mutations in the phospholipid transport genes contribute to 294 the observed cross-resistance patterns in the evolved lines ( Figure 6a ).
295
To test this hypothesis, we reconstructed an adaptive mutation (A342mlaD*) which was 296 identified in a HBD-3-evolved line by inserting it into the mlaD gene of wild-type E. coli. Then, we 297 measured the susceptibility of this mutant to a selected set of membrane-targeting (C1-C2) and 298 intracellular-targeting AMPs (C3-C4). As expected, the strain carrying the A342mlaD* mutation 299 showed a decreased susceptibility to membrane-targeting AMPs and an increased susceptibility 300 to intracellular-targeting ones, similarly to the MlaD overexpression strain (Figure 6b , for MIC 301 curves, see Supplementary Figure 12 ). In agreement with these findings, measuring the net neg-302 ative surface charge and the membrane potential of the mutant strain confirmed the same muta-303 tional effects as in the case of the mlaD overexpression and deletion strains (Figure 6c and 6d ).
304
In sum, the chemical-genetic profiles predicted the observed cross-resistance patterns of 305 the HBD-3-evolved lines and illuminated the mechanistic basis thereof.
307

Discussion
308
This work systematically mapped the genetic determinants of AMP resistance by chemical-ge-309 netic profiling in E. coli (Figure 1 ). We report that AMP resistance is influenced by a large set of 310 functionally diverse genes, and yet these genes overlap only to a limited extent between AMPs. 
320
The results presented in this study have important implications for the development of 
335
The large diversity of genes that influence AMP resistance upon overexpression indicates 336 that bacterial susceptibility to AMPs is coupled to the general physiology of the bacterial cell, and 337 in particular to alterations in membrane composition. This idea also provides an explanation to a 338 recent finding that antibiotic resistance mutations in membrane proteins frequently induce collat-339 eral sensitivity to AMPs through pleiotropic side effects that alter membrane composition 27 . In-340 deed, the overrepresentation of collateral sensitivity interactions among AMP resistance determi-341 nants implies that evolving AMP resistance requires the optimization of many traits simultane-342 ously. As a consequence, bacterial cells potentially harbor a large mutational target to alter AMP 343 resistance, however, such mutations often have negative trade-offs with other cellular traits.
344
Collateral sensitivity between AMPs is best exemplified by the Mla pathway. Several stud- 
348
Here, we demonstrated that a loss-of-function mutation in mlaD decreases the net negative sur-349 face charge of the bacterial membrane and, eventually, causes a somewhat increased resistance 12 to human membrane-targeting AMPs (Figure 5a 
402
Then, from these wells, cells were split into four equal proportion and each was transferred into 403 20 mL of MS medium supplemented with the corresponding AMP in four different concentrations 404 in the range that slowed down growth by two-fold in the microtitre plate. Then, following exponen-405 tial growth, out of the four 20 mL cultures those that showed again a two-fold increase in doubling 406 time were selected for further analysis. The rationale for this 2-step process was to maintain com- (Supplementary Figure 14) . The lower mode of the distribution corresponds 443 to ORFs that were not present in the sample. The upper mode represents those ORFs whose 444 growth was unaffected by overexpression (i.e. no fitness effect). To make different samples com-445 parable, the two modes of the distribution of each sample were set to two predefined values.
446
These values were chosen such that the original scale of the data was retained. In order to align 447 the modes between samples, we introduced two normalization steps: one before and one after 448 loglinear transformation. The first normalization step identified the lower mode corresponding to 449 the absent strains and added a constant to shift the lower mode to zero. Next, we performed the 450 loglinear transformation step described above. The second normalization step was a linear trans-451 formation moving the upper mode to a higher predefined value. Following these normalization 452 steps, genes that were close to the lower mode in the untreated samples were discarded from 453 the analysis as these represent strains that displayed poor growth even in the absence of drug 454 treatment (that is, AMP sensitivity could not be reliably detected). A differential growth score (i.e. 
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As a first step, we removed genes that did not show AMP-specific phenotypes across 467 treatments since these genes would be uninformative for clustering. To this end, we retained only 468 those genes that showed significant differences in their fold-change values between AMPs com-469 pared to their variances across replicate measurements within AMPs as assessed by F-tests 470 (p<0.01). This resulted in a set of 2146 genes kept for clustering. Next, we employed a distance 471 metric, normalized variation of information, to measure distances between AMP chemical-genetic 472 profiles. The normalized variation of information is closely related to mutual information but has 473 the advantage of being a true distance metric. Importantly, normalized variation of information 474 gives more weight to rare overlaps of resistance/sensitivity phenotypes between AMPs, unlike the 475 commonly used Euclidean distance. Normalized variation of information (NVI) between AMP pairs 476 was calculated as follows: NVI= (H -I) / H where H is the entropy and I is the mutual information.
477
Based on this distance measure, we then generated 75,000 clusters of AMPs by perturb- 
497
Analogous to our E. coli synthetic genetic array approach 58 , our chemical-genetics screening 498 strategy involves robotic pinning of each Kan R marked single essential gene hypomorph arrayed 499 in 384 colony format on Luria Broth (LB) medium, in quadruplicate, onto the minimal medium containing AMPs under a selected concentration, in two replicates, generating eight replicates in 501 total for each essential gene hypomorph. The sub-inhibitory concentration was chosen based on 502 50% growth inhibition of wild-type cells using a serial dilution. In parallel, we also prepared two 503 replicates of control plates containing arrayed essential gene hypomorphic strains pinned onto 504 minimal media without AMPs. After incubation at 32°C for 20 h, the plates (with and without AMPs) 505 were digitally imaged and colony sizes were extracted from the imaged plates using an adapted 506 version of the gitter toolbox 60 . The resulting raw colony size (proxy for cell growth) from each 507 screen, with and without AMP, was normalized using SGAtools suite 61 , with default parameters.
508
The normalized colony sizes from the AMP plate was subtracted from their corresponding colony 509 screened without AMP to estimate the final hypomorphic-strain fitness score (sensitive or re-510 sistant), which is as an average of all eight replicate measurements recorded for each hypo- Supplementary Table 7 .
562
We calculated the enrichment of phospholipid and lipopolysaccharide transport/binding 563 functions among the set of E. coli genes that were mutated in HBD-3-adapted lines. The same 564 enrichment analysis was also carried out for those genes that showed collateral sensitivity.
565
Genes related to phospholipid and lipopolysaccharide transport/binding function were selected 566 from a previous study 27 .
567
Determination of minimum inhibitory concentration (MIC). Minimum inhibitory concentrations
568
(MIC) were determined with a standard serial broth dilution technique 69 . Briefly, from a stock so-569 lution of an AMP, 12-steps serial dilution was prepared in fresh MS medium in 96-well microtiter 570 plates. Each AMP was represented in 11 different concentrations (3 wells/AMP concentra-571 tion/strain). Three wells contained only medium to check the growth in the absence of AMP. After 572 overnight growth in MS medium supplemented with chloramphenicol, bacterial strains were di-573 luted 20-fold into fresh MS medium and grown until the cell density reached OD600 ~1. Cells were 574 induced by 100 µM of IPTG and incubated for 1 h at 30°C with continuous shaking at 300 rpm.
575
Following incubation, approximately half-million cells were inoculated into the wells of the 96-well 576 microtiter plate with a 96-pin replicator. We used three independent replicates for each strain and 
705
All scripts and other files needed to reproduce our analyses will be available at https://github.com in Supplementary Table 2 . b, Heatmap shows the corrected Jaccard similarity indices calculated 919 for resistance-(blue) and sensitivity-conferring genes (red) between AMP pairs based on the 920 overexpression screen (see Methods for calculation of corrected Jaccard indices, n = 210, that 921 is, the number of AMP pairs used for calculating the Jaccard-similarity indices). The darker the 922 color the higher the overlap of gene sets between AMP pairs. Data is provided in Supplementary 923 Table 6 . c, The overlaps in the latent resistomes (genes conferring resistance upon overexpres-924 sion) between AMP pairs belonging to different chemical-genetic clusters. Significant difference: 925 ** P = 0.009 from two-sided Mann-Whitney U test, n = 54 and n = 51 for between C1, C2 and C3, 926 C4, and others, respectively. d, Heatmap shows the corrected Jaccard similarity indices calcu-927 lated for resistant (blue) and sensitive (red) chemical-genetic interactions with partially-depleted 928 essential genes (see Methods). Data is provided in Supplementary Table 8 . e, Sets of essential 929 genes that simultaneously confer AMP resistance when overexpressed and sensitivity when de- 
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Collateral sensitivity effects were especially pronounced between AMP pairs with different broad 939 mechanism of action, that is, between membrane-targeting (C1, C2) and intracellular-targeting 940 (C3, C4), as compared to AMP pairs from the same cluster. Significant difference: *** P = 2.1*10 -941 07 from two-tailed unpaired t-test, n = 108 and 46 for pairs of AMPs between C1, C2 and C3, C4, 942 and those within cluster, respectively. Y-axis shows odds ratio (log10) of enrichment of collateral 943 sensitivity interactions between AMP pairs. Data is provided in Supplementary Table 6 . 
950
were compared to corresponding wild-type control strains (see Supplementary Figures 8 and 9 ).
951
Dashed lines represent previously defined cut-offs for resistance (≥1.2 x MIC of the control) and 952 sensitivity (≤0.8 x MIC of the control) 27 . b, Decreased net negative surface charge of the mlaD 953 overexpression and deletion strains. Significant differences: ** P = 0.0021 and P = 0.0021 for 954 WT+empty vector vs overexpression and WT vs deletion strain, respectively, from two-sided
955
Mann-Whitney U test, n = 6 biological replicates for each genotype. Charge measurement was
